Cargando…
Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness
Initial controlled trials of the serotonergic antidepressant fluvoxamine showed promise for treatment of mild to moderate COVID-19 in outpatients, although more recent outpatient data have been less encouraging. Turning to studies of hospitalized patients, a retrospective cohort study by Hoertel and...
Autores principales: | Brennan, Brian P., Schnabel, Jiana, Pope, Harrison G., Hudson, James I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520125/ https://www.ncbi.nlm.nih.gov/pubmed/36186877 http://dx.doi.org/10.3389/fpsyt.2022.951065 |
Ejemplares similares
-
Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness
por: Roughan, William H., et al.
Publicado: (2021) -
The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol: A Naturalistic and Retrospective Study
por: Swoboda, Marleen M. M., et al.
Publicado: (2022) -
Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review
por: Gramaglia, Carla, et al.
Publicado: (2018) -
The Next Generation of Clinical Studies with Antidepressants in Bipolar Disorder
por: Machado-Vieira, Rodrigo
Publicado: (2014) -
A Review of Novel Antidepressants: A Guide for Clinicians
por: Faquih, Amber E, et al.
Publicado: (2019)